Welcome to homework assignment CAS 1.6 in the Cannabis for Anxiety seminar from Higher Learning LV. This assignment focuses on the therapeutic application of cannabis for anxiety and, specifically, a 2023 study about how registered patients in the United Kingdom medical cannabis program who feature anxiety have responded to medical cannabis.
After you complete this assignment, use the button at the bottom to return to the Cannabis for Anxiety Seminar master page.
A 2023 study entitled "An Observational Study of Safety and Clinical Outcome Measures Across Patient Groups in the United Kingdom Medical Cannabis Registry" that was published in the journal Expert Review of Clinical Pharmacology explored the potential efficacy of medical cannabis for anxiety. All participants were enrolled in the United Kingdom Medical Cannabis Registry.
Participants were measured for anxiety level and sleep quality. Their baseline metrics, gathered at the launch of the study, were compared to follow-up sessions after one, three, six, and 12 months.